AAD 2017

Multispecialty collaborationCollaboration with specialists in other fields can improve outcomes for patients with skin cancer, and it can be personally and professionally rewarding for the dermatologist, according to one expert.
Teledermatology viable for skin cancer diagnosisTeledermatology may play a role in skin cancer diagnsosis, an accumulating body of literature indicates, says one dermatologist.
New systemic psoriasis treatments keep raising barBiologic inhibitors of IL-23 and IL-17 are commonly delivering responses of PASI 90 and above, says an expert.
Get to know your practicePerformance metrics are one way to take the guesswork out of physician group practice planning and decision making, according to one dermatologist.
From mole to melanomaThere is a genetically intermediate state of melanocytic neoplasia and these findings could someday help doctors identify high-risk lesions to remove before they become malignant.
Wound healing and the HS patientPatients with hidradenitis suppurativa (HS) need wound care not only after surgery, to address HS scarring and tunneling from sinus tracts; they also need ongoing wound care for lesions that might be draining, says one dermatologist.
Melanoma surgical management guidelinesAll surgical management of melanoma is defined by Breslow thickness. For melanoma less than 1 mm in thickness, typically a SLNB is not required. Future imaging devices may better delineate the extent and depth of the tumor in vivo.
The big squeezeLimited provider networks are cutting more than costs; these narrow networks are cutting dermatologists. One expert shares insight on what derms need to know.
A new class steps forwardPhosphodiesterase (PDE) inhibitors including apremilast and crisaborole ointment may provide safer alternatives than traditional steroid-sparing agents for psoriasis and atopic dermatitis. Side effects of apremilast may include GI symptoms, weight loss and depression, and taking apremilast with anti-seizure drugs or rifampin lowers apremilast blood levels, Apremilast is being studied in inflammatory bowel disease, Behcet's disease and pediatric psoriasis, and may have a place in the treatment of hidradenitis suppurativa (HS).
Derm sounds alarm about Hispanics and skin cancerDermatologists should be versed and informed about the specific attitudes and lifestyle habits that could be fueling rising skin cancer risk in the Hispanic population, according to dermatologist Maritza I. Perez, M.D.